char = H;code = 72
Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.char = F;code = 70
Publication: J. Histochem. Cytochem. 2006 Jan ;54(1)::3-11.
Publication Date: 2006 Jan
Study Author(s): Guarner, Jeannette;Zaki, Sherif R;
Institution: Infectious Disease Pathology Activity, Centers for Disease Control and Prevention, Mailstop G32, 1600 Clifton Rd. NE, Atlanta, GA 30333, USA.
[email protected]
Shortcut link to this study:
From October to November 2001, the inhalational and cutaneous anthrax cases that occurred in the U.S. underscored the importance of recognizing the clinical and pathological features of infectious agents that can be used in acts of terrorism. Early confirmation of bio-terrorist acts can only be performed by making organism-specific diagnosis of cases with clinical and pathologic syndromes that could be caused by possible bioterrorism weapons. Recognition and diagnosis of these cases is central to establish adequate responses. This review will examine the events that occurred during the anthrax bio-terrorist attack with specific emphasis on the role of pathology and immunohistochemistry and will describe the histopathologic features of category A bioterrorism agents (anthrax, plague, tularemia, botulism, smallpox, and viral hemorrhagic fevers).
PMID: 16148309
How is this determined?
